(E)-5-(2,3-Dichlorobenzylidene)-2-mercaptothiazol-4(5H)-one

Catalog No. :
ACVHJU413
CAS No. :
90407-17-3
Molecular Formula :
C10H5Cl2NOS2
Molecular Weight :
290.20

IUPAC Name:(E)-5-(2,3-dichlorobenzylidene)-2-thioxothiazolidin-4-one

(E)-5-(2,3-Dichlorobenzylidene)-2-mercaptothiazol-4(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$160.00Login to see priceInquiryInquiry
5g95%$509.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-5-(2,3-Dichlorobenzylidene)-2-mercaptothiazol-4(5H)-one
IUPAC Name(E)-5-(2,3-dichlorobenzylidene)-2-thioxothiazolidin-4-one
MDL No.MFCD04969008
Molecular FormulaC10H5Cl2NOS2
Molecular Weight290.20
SMILESO=C1N=C(S)S/C1=C/C2=CC=CC(Cl)=C2Cl
InChI KeyJMNPBVGLEZGPIF-QPJJXVBHSA-N
SynonymAlbb-009162;(5E)-5-(2,3-dichlorobenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one(SALTDATA: FREE);(5Z)-5-(2,3-dichlorobenzylidene)-2-thioxo-thiazolidin-4-one;(5Z)-5-[(2,3-dichlorophenyl)methylene]-2-thioxo-4-thiazolidinone;(5Z)-5-[(2,3-dichlorophenyl)methylene]-2-thioxo-thiazolidin-4-one;(5Z)-5-[(2,3-dichlorophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one;5-(2,3-dichlorobenzylidene)-2-thioxo-thiazolidin-4-one;(5E)-5-[(2,3-dichlorophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
CAS No.90407-17-3

Synthetic Route by SureRoute

1. ACVHJU413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADET348 route compound structure diagram
    ACADET348141-84-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVHJU413 route product structure diagram
    ACVHJU41390407-17-3
Inquiry

2. ACVHJU413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVHJU413 route product structure diagram
    ACVHJU41390407-17-3
Inquiry

Comments (0)